Back to Trades
Other3
Kailera Therapeutics, Inc.
KLRA
Total Value
$NaN
Company Information
- Company Name
- Kailera Therapeutics, Inc.
- Ticker Symbol
- KLRA
- CIK
- 0002096997
Insider Information
- Role
- Insider
- Location
- NEW YORK, NY
Filing Details
- Filing Date
- Apr 16, 2026
- Transaction Date
- Apr 16, 2026
- Accession Number
- 0001231919-26-000369
- Form Type
- 3
Footnotes
- (F1)Each share of Series A Preferred Stock and Series B Preferred Stock has no expiration date and will automatically convert into shares of Common Stock on a 1-for-1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration.
- (F2)Held by certain affiliated funds managed by RTW Investments, LP ("RTW"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein.